| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | COR Cencora, Inc. | Krikorian Lazarus46 | SVP &Chief Accounting Officer | Sell | 1,816 | $250.42 | $454,753.64 | -7.6% | +2.1% | +34.1% | |
| Dec 2, 2024 | LH Labcorp Holdings Inc. | Gilliland Dwight Gary49 | Director | Sell | 1,000 | $241.00 | $241,000.00 | -11.5% | +5.6% | +10.5% | |
| Dec 2, 2024 | ZYXIQ Zynex Inc | Moorhead Daniel J80 | Chief Financial Officer | Sell | 10,000 | $8.08 | $80,800.00 | -22.1% | -12.3% | -85.8% | |
| Dec 2, 2024 | LH Labcorp Holdings Inc. | Eisenberg Glenn A | Executive Vice President | Sell | 11,711 | $240.43 | $2,815,651.14 | -27.2% | +5.6% | +10.5% | |
| Dec 2, 2024 | OSCR Oscar Health, Inc. | Baltrus Victoria47 | Chief Accounting Officer | Sell | 8,078 | $18.08 | $146,028.91 | -2.7% | -18.1% | -8.6% | |
| Dec 2, 2024 | OSCR Oscar Health, Inc. | Schlosser Mario55 | President Of Technology &CTO | Sell | 6,516 | $18.08 | $117,792.09 | -3.8% | -18.1% | -8.6% | |
| Dec 2, 2024 | OSCR Oscar Health, Inc. | Wolin Steven60 | Chief Operating Officer | Sell | 19,580 | $18.08 | $353,955.33 | -8.7% | -18.1% | -8.6% | |
| Dec 2, 2024 | OSCR Oscar Health, Inc. | Blackley Richard Scott56 | Chief Financial Officer | Sell | 25,279 | $18.08 | $456,978.49 | -1.4% | -18.1% | -8.6% | |
| Dec 2, 2024 | OSCR Oscar Health, Inc. | Bopitiya Ranmali48 | EVP &Chief Legal Officer | Sell | 19,157 | $18.08 | $346,308.44 | -3.8% | -18.1% | -8.6% | |
| Dec 2, 2024 | OSCR Oscar Health, Inc. | Quane Alessandrea C.51 | EVP, Chief Insurance Officer | Sell | 26,895 | $18.08 | $486,191.09 | -3.1% | -18.1% | -8.6% | |
| Dec 2, 2024 | TOI Oncology Institute, Inc. | Hively Brad79 | Director | Buy | 300,000 | $0.17 | $50,000.00 | +30.5% | +365.6% | +1803.5% | |
| Nov 29, 2024 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 35,146 | $163.07 | $5,731,301.51 | -24.4% | +5.5% | +16.3% | |
| Nov 29, 2024 | SRTA Strata Critical Medical, Inc. | Heyburn William A.56 | Chief Financial Officer | Sell | 23,815 | $5.02 | $119,627.51 | -1.7% | -28.7% | -8.4% | |
| Nov 29, 2024 | SRTA Strata Critical Medical, Inc. | Tomkiel Melissa M.56 | President And General Counsel | Sell | 111,377 | $4.50 | $501,620.07 | -3.3% | -28.7% | -8.4% | |
| Nov 27, 2024 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 33,103 | $162.99 | $5,395,484.41 | -16.7% | +7.4% | +15.8% | |
| Nov 27, 2024 | LFST Lifestance Health Group, Inc. | Bessler Robert67 | Director | Sell | 75,000 | $7.54 | $565,500.00 | -2.5% | +0.1% | -13.4% | |
| Nov 27, 2024 | CHE Chemed Corp | Lee Spencer S71 | Executive Vice President | Sell | 732 | $575.62 | $421,356.04 | -3.8% | -3.6% | -23.1% | |
| Nov 27, 2024 | ALHC Alignment Healthcare, Inc. | Kardes Hakan | Chief Experience Officer | Sell | 35,000 | $12.80 | $448,140.00 | -9.8% | +4.4% | +49.7% | |
| Nov 26, 2024 | SEM Select Medical Holdings Corp | Tavenner Marilyn B | Director | Sell | 32,000 | $21.09 | $674,880.00 | -59.3% | -13.2% | -27.8% | |
| Nov 26, 2024 | SEM Select Medical Holdings Corp | Ortenzio Robert A55 | Executive Chairman | Sell | 3,804,805 | $19.55 | $74,383,937.75 | -100% | -13.2% | -27.8% | |
| Nov 25, 2024 | ADUS Addus Homecare Corp | Allison R Dirk65 | CEO And Chairman | Sell | 12,500 | $123.16 | $1,539,555.91 | -2.1% | -11.5% | -2.0% | |
| Nov 25, 2024 | COR Cencora, Inc. | Collis Steven H | Executive Chairman | Sell | 50,000 | $243.98 | $12,198,750.00 | -13.3% | +0.0% | +53.4% | |
| Nov 25, 2024 | CHE Chemed Corp | McNamara Kevin J57 | President And CEO | Sell | 2,000 | $572.77 | $1,145,540.00 | -1.9% | -4.4% | -23.0% | |
| Nov 23, 2024 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 16,660 | $54.01 | $899,792.85 | -0.4% | +50.3% | +70.5% | |
| Nov 22, 2024 | CHE Chemed Corp | Lee Spencer S71 | Executive Vice President | Sell | 1,000 | $565.71 | $565,710.00 | -5.0% | -3.7% | -22.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.